{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:32:16Z","timestamp":1793089936362,"version":"4.5.0"},"reference-count":38,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2026,9,22]]},"DOI":"10.1080\/14656566.2026.2732054","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:51:45Z","timestamp":1788879105000},"page":"1535-1545","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating enlicitide decanoate: first oral PCSK9 inhibitor for the treatment of adults with hypercholesterolemia"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-1730","authenticated-orcid":false,"given":"Christie M.","family":"Ballantyne","sequence":"first","affiliation":[{"name":"Texas Heart Institute at Baylor College of Medicine","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2948-6257","authenticated-orcid":false,"given":"Angela","family":"Pirillo","sequence":"additional","affiliation":[{"name":"E. Bassini Hospital","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-2094","authenticated-orcid":false,"given":"Alberico L.","family":"Catapano","sequence":"additional","affiliation":[{"name":"IRCCS MultiMedica","place":["Milan, Italy"]},{"name":"University of Milan","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00541-4"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf190"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.11.016"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.1810"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa047"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12960"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"issue":"14","key":"e_1_3_4_11_1","first-page":"1366","article-title":"ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-Cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American college of cardiology solution Set oversight committee","volume":"80","author":"Committee W","year":"2022","unstructured":"Committee W, Lloyd-Jones DM, Morris PB, et al. ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-Cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American college of cardiology solution Set oversight committee. J Am Coll Cardiol. 2022;80(14):1366\u20131418.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801174"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac594"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.063372"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.20620"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2511002"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2026.03.036"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab035"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702027200"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20882"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1161"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001632"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054013"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2514428"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913805"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912387"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2026.101662"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2026.02.664"},{"key":"e_1_3_4_30_1","unstructured":"Sharp M Dohme LLC Dohme LLC. LIPFENDRA (enlicitide) tablets: US prescribing information. Rahway NJ: Merck Sharp; 2026 [cited 2026 Sep 1]. Available from: https:\/\/www.merck.com\/product\/usa\/pi_circulars\/l\/lipfendra\/lipfendra_pi.pdf"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.02.018"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwag273"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2026.03.019"},{"key":"e_1_3_4_34_1","unstructured":"U.S. Food and Drug Administration. FDA approval letter NDA 220848 (Lipfendra\/enlicitide). [cited 2026 Aug 28]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2026\/220848Orig1s000ltr.pdf"},{"key":"e_1_3_4_35_1","unstructured":"European Medicines Agency. Decision on the acceptance of a modification of an agreed paediatric investigation plan for enlicitide (decanoate): EMA\/PE\/0000228536. Amsterdam: European Medicines Agency; 2025 Mar 19 [cited 2026 Aug 28]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/paediatric-investigation-plans\/ema-pe-0000228536#decision"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2026.102733"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-024-02868-z"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02036-3"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvz079"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2732054","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14656566.2026.2732054","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2026.2732054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:32:22Z","timestamp":1793086342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2026.2732054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":38,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,9,22]]}},"alternative-id":["10.1080\/14656566.2026.2732054"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2026.2732054","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}